36C24527Q0053.docx

Sources Sought Notice Sources Sought Notice

GENERAL INFORMATION

SET-ASIDE

Louis A Johnson, VAMC Contracting Office (90C) 1 Med Center DR Clarksburg WV 26301-4199

POINT OF CONTACT*

Contracting Officer Alison Klein alison.klein@va.gov

(304) 623-3461 x4143

PLACE OF PERFORMANCE

10 N Greene Street

Baltimore Maryland

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

DESCRIPTION

This RFI is solely for information and planning purposes and does not constitute a solicitation or obligation on the part of the Government. Per FAR 15.201(e), responses to this notice are not considered offers, shall not be used as a proposal, and cannot be accepted by the Government to form a binding contract. Neither unsolicited proposals nor any other kinds of offers will be considered in response to this notice. No evaluation letters and/or results will be issued to the respondents; however, the Government does reserve the right to contact any respondent and/or respondent reference to obtain additional information. At this time, no solicitation exists; therefore, please do not request a copy of the solicitation. Any resulting procurement action will be the subject of a separate, future announcement. The information is provided for discussion purposes and any potential strategy for this acquisition may change prior to any solicitation release. The acquisition strategy, evaluation methodology, contract type, and any other acquisition decisions are to be determined.

Background. The offeror shall provide to the Veterans Affairs Medical Health Care System at Baltimore VAMC all reagents and supplies for flow cytometry testing in the Hematology section of Pathology and Laboratory Medicine Service. The reagents/supplies will be used for CD4/CD8 count testing and the phenotyping of white blood cells in the leukemia and lymphoma assay using the Becton Dickinson FACSLyric. QC material and calibration material are used for the detection of voltages and spectral overlap to monitor optimal cytometer settings, checks, and track the daily performance.

Performance Period: 12/03/2026 to 12/02/2027 Quantities are estimates:

RESPONSES:

1. Please include descriptive literature demonstrating the product meets or exceeds the brand name product specified above.

2. Please provide any product solution or configuration so long as they are equivalent to the brand name product.

3. Responses can include any additional product that may be beneficial. These items must be clearly identified by brand name and part number.

PLEASE PROVIDE THE FOLLOWING ADDITIONAL INFORMATION:

1. Full name and address of company

2. DUNS number/ CAGE Code/ SAM UEI

3. Business Size

4. Manufacturer or Distributor

5. If distributor, provide full name, business size, and address of manufacturer.

6. Country of Origin designation for all products.

7. Technical Literature that clearly shows product(s) are equivalent.

8. Any additional product solution or configuration that would be beneficial to the functionality of the product line identified.

9. Authorized Distributor Letter Certified by OEM with a current date.

Although not required, vendors responding to this Sources Sought may also submit a Capabilities Statement.

Sources Sought Notice